Minerva Neurosciences (NERV) EBITDA (2013 - 2026)
Minerva Neurosciences (NERV) EBITDA from Jun 30, 2013 to Mar 31, 2026. The TTM Minerva Neurosciences (NERV) EBITDA is -$137M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Minerva Neurosciences (NERV) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +616.63% |
| 3 Years TTM | +70.21% |
| 10 Years TTM | +17.19% |
| All Time TTM | +17.39% |
Annual EBITDA change of Minerva Neurosciences (NERV)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$125M | +730.46% |
| 2025 | -$15M | -30.86% |
| 2024 | -$22M | -5.50% |
| 2023 | -$23M | -28.03% |
| 2022 | -$32M | -37.90% |
| 2021 | -$52M | -2880.11% |
| 2020 | $1.86M | -102.45% |
| 2019 | -$76M | +46.68% |
| 2018 | -$52M | +25.63% |
| 2017 | -$41M | +36.43% |
| 2016 | -$30M | +15.64% |
| 2015 | -$26M | -52.43% |
| 2014 | -$55M | +2474.65% |
| 2013 | -$2.13M | N/A |